Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

N-Methylhomoveratrylamine

    • Product Name N-Methylhomoveratrylamine
    • Alias NMHVA
    • Einecs 629-022-6
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    930318

    Chemical Name N-Methylhomoveratrylamine
    Cas Number 13189-14-9
    Molecular Formula C11H17NO2
    Molecular Weight 195.26
    Iupac Name 1-(3,4-dimethoxyphenyl)-N-methylpropan-2-amine
    Synonyms 3,4-Dimethoxy-N-methyl-2-phenylpropan-1-amine
    Appearance Colorless to pale yellow liquid
    Boiling Point 332.7°C at 760 mmHg
    Density 1.04 g/cm3
    Solubility Soluble in organic solvents
    Smiles CC(CC1=CC(=C(C=C1)OC)OC)NC
    Inchi InChI=1S/C11H17NO2/c1-8(12-2)7-9-5-6-10(13-3)11(4)14-9/h5-6,8,12H,7H2,1-4H3

    As an accredited N-Methylhomoveratrylamine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing Amber glass bottle containing 25 grams of N-Methylhomoveratrylamine, sealed with a screw cap, labeled with hazard information and CAS number.
    Shipping N-Methylhomoveratrylamine is shipped in secure, tightly sealed containers, protected from light, moisture, and incompatible substances. The chemical is transported according to applicable regulations for laboratory chemicals, with appropriate labeling and documentation. Shipping may require temperature control, hazard labeling, and adherence to local, national, and international regulations for safe handling and transit.
    Storage N-Methylhomoveratrylamine should be stored in a cool, dry, and well-ventilated area, away from direct sunlight and sources of ignition. Keep the container tightly sealed and store under an inert atmosphere, such as nitrogen, if possible. Avoid incompatible substances, especially strong oxidizers and acids. Ensure the storage area is secure and clearly labeled, following all relevant chemical safety regulations.
    Application of N-Methylhomoveratrylamine

    Applications of N-Methylhomoveratrylamine in Industrial Manufacturing

    N-Methylhomoveratrylamine serves as a critical synthesis intermediate for a range of advanced organic compounds. As a manufacturer, we supply this raw material to highly specialized downstream sectors that require stringent process controls and compliance with industry standards. Below are the principal industrial application paths and technical integrations for N-Methylhomoveratrylamine.

    1. Pharmaceutical Intermediates for CNS Drug Synthesis

    Leading pharmaceutical manufacturers use N-Methylhomoveratrylamine as an intermediate in the multi-step synthesis of central nervous system (CNS) therapeutics, notably selective monoamine oxidase inhibitors and related neuroactive compounds. The product is introduced after primary amine protection stages, acting as a methylated amine donor before downstream condensation, cyclization, or alkylation reactions. This application adheres strictly to pharmacopeial-grade material quality, validated by regulatory filings. Finished products include prescription CNS medications and alkaloid derivatives.

    Industry compliance standards

    • CGMP compliance (ICH Q7)
    • USP/NF monographs analysis for impurities
    • EMA guidelines for active substance intermediates
    • ICH Q3A/B for impurity limits

    Typical usage ratio

    • 0.2–0.5 molar equivalents in reaction scale, adjusted to maintain target active pharmaceutical ingredient (API) purity

    Downstream process integration

    • Introduced after amine protection or activation steps in batch reactors under controlled temperature and inert atmosphere
    • Feeds into subsequent condensation or alkylation steps

    Final product types

    • CNS active pharmaceutical ingredients (e.g., MAOI drugs, psychoactive compounds)
    • Advanced alkaloid intermediates
    • Clinical trial materials
    • Reference standards for pharma R&D

    2. Agrochemical Active Ingredient Synthesis

    Major agrochemical producers apply N-Methylhomoveratrylamine for the tailored synthesis of pesticide and herbicide building blocks. The methylated amine structure affords targeted functional group introduction, optimizing the physicochemical properties of select active pesticide ingredients. Entry into the synthetic route typically occurs post-halogenation or aromatic ring substitution, ensuring compatibility with controlled-pressure organic synthesis systems. The process requires documented material traceability and impurity control.

    Industry compliance standards

    • OECD Principles of Good Laboratory Practice (GLP)
    • EPA 40 CFR Part 158 for pesticide data requirements
    • ISO 9001:2015 quality management system
    • REACH registration for EU

    Typical usage ratio

    • Ranged at 3–6% weight/weight in synthesis, depending on the specific structure and sequence of target active ingredient

    Downstream process integration

    • Charged during mid-stage, following aromatic substitution, combined under reflux with halogenated intermediates
    • Processed in stainless steel or glass-lined reactors

    Final product types

    • Herbicide and pesticide actives (e.g., selective weed control agents)
    • Agrochemical research compounds
    • Pre-emergent crop protection formulas
    • Blended tank-mix solutions for field application testing

    3. Fragrance and Aroma Chemical Development

    Leading aroma and specialty chemical firms utilize N-Methylhomoveratrylamine for the manufacture of musk analogues and fragrance compounds, exploiting its methylated aromatic backbone to impart distinct olfactory notes. Controlled reaction sequences—such as Mannich or reductive amination—integrate the amine during late-stage synthesis, enabling precision tuning of volatility and tenacity. Downstream QC laboratories verify residual solvents and amine content as per global fragrance safety protocols.

    Industry compliance standards

    • IFRA Standards (International Fragrance Association)
    • EU Cosmetics Regulation (EC) No 1223/2009
    • ISO 9235 (Aromatic Natural Raw Materials)
    • FEMA GRAS status requirements

    Typical usage ratio

    • Integrated at 1–4% weight basis in fragrance concentrate synthesis, adjusted for final note strength and toxicological thresholds

    Downstream process integration

    • Added following initial backbone synthesis, processed in batch reactors before purification or distillation
    • QC verifies amine levels in the concentrate batch

    Final product types

    • Base musks for perfumery
    • Industrial aroma compounds for household products
    • Functional fragrances for consumer care
    • Customized aroma blends for flavor and fragrance houses

    4. Fine Chemical Synthesis for Fluorescent Dye Production

    Producers of high-purity fluorescent and luminescent dyes employ N-Methylhomoveratrylamine for the formation of complex heterocyclic cores. This raw material advances integration during cyclization or amide formation steps within multi-stage batch systems. The resulting compounds exhibit specific absorption spectra, key for analytical and imaging applications. All production runs maintain contamination-free environments to pass optical performance and emission purity criteria.

    Industry compliance standards

    • ISO 17025 for laboratory quality control
    • IEC 62471 for lamp and system photobiological safety
    • RoHS Directive (2011/65/EU) substance limitations
    • EN 62493 for evaluation of human exposure to electromagnetic fields

    Typical usage ratio

    • 0.5–2 molar equivalents, tightly controlled to dictate chromophore formation and quantum yield

    Downstream process integration

    • Introduced during penultimate synthetic step, typically cyclization or amidation, followed by refinement via crystallization or chromatography
    • QC confirms target emission wavelength and purity

    Final product types

    • Fluorescent dyes for spectroscopy
    • Labeling reagents for biomedical imaging
    • Optical brighteners for specialty plastics
    • Laser dyes for photonics research

    5. API-Grade Intermediate for Veterinary Compounds

    Veterinary pharmaceutical manufacturers incorporate N-Methylhomoveratrylamine as a key intermediate in the synthesis of antiemetic and sedative agents for animal healthcare. The material is charged during controlled, closed-system reactions under GMP-certified facilities. Processes closely monitor impurity profiles and retention samples, ensuring full traceability for regulatory inspections. Rigorous validation confirms the amine's structure contribution to bioactive veterinary formulations.

    Industry compliance standards

    • VICH GL10/11 for GMP of veterinary medicinal products
    • BPOC (Brazilian Pharmacopoeia), Ph. Eur. (European Pharmacopoeia)
    • FDA 21 CFR 514 animal drug manufacturing
    • ISO 13485 for medical devices if used as diagnostic agent intermediate

    Typical usage ratio

    • 0.1–0.4 molar equivalents, specification set by target animal dosage form and regulatory submission

    Downstream process integration

    • Added post-activation, before final condensation/cyclization steps
    • Integrated in high-containment suites for veterinary API batch production

    Final product types

    • Veterinary CNS active ingredients
    • Animal sedative and antiemetic APIs
    • Bulk veterinary formulation intermediates
    • Synthesis reference standards for regulatory approval

    6. R&D Use for Specialty Polymer Synthesis

    Polymer research institutes and advanced material developers use N-Methylhomoveratrylamine as a monomeric functionalizing agent for precision polymer modification projects. The aromatic amine moiety reacts during copolymer grafting or crosslinking stages to alter matrix flexibility and chemical resistance properties. Application-specific projects adhere to proprietary or published polymerization protocols under inert, controlled lab-scale settings, with experimental logs maintained for technology transfer.

    Industry compliance standards

    • ISO 9001 for R&D quality assurance
    • GLP (Good Laboratory Practice) for reproducibility
    • EPA TSCA for polymer research notification
    • Material transfer agreements (MTAs) for collaborations

    Typical usage ratio

    • Variable: 0.5–7% wt/wt relative to base polymer, fine-tuned according to targeted copolymer properties and mechanical testing results

    Downstream process integration

    • Introduced at grafting or coupling step during batch or continuous process, under controlled reactivity and temperature
    • Cured and characterized for functionalization degree

    Final product types

    • Functionalized engineering plastics
    • Lab-scale specialty resins
    • Advanced polymers for electronics R&D
    • Chemical-resistant material prototypes
    Free Quote

    Competitive N-Methylhomoveratrylamine prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    N-Methylhomoveratrylamine: A Closer Look from the Manufacturer’s Perspective

    Direct Experience Working with N-Methylhomoveratrylamine

    Inside a manufacturing facility, each substance we produce builds on years of accumulated know-how, repeated analysis, and constant tinkering to push benchmarks higher. N-Methylhomoveratrylamine stands out due to the care and fine-tuning built into every batch. This amine draws industry attention for its unique chemical profile, which places it in a class of starting materials critical for advanced organic synthesis. We have spent years developing means to stabilize its structure and ensure purity, helping customers achieve consistent results in research and industrial production.

    Our teams regularly handle customer feedback and track usage trends, allowing us to respond not by guessing, but by implementing real improvements. It’s not uncommon for a process chemist or research director to raise a query about minor impurities or an unexpected shift in chromatographic behavior. We've seen how small, overlooked variances can derail a synthesis or reduce output yield, so every step in our process aims for control and predictability. In our work, N-Methylhomoveratrylamine arrived as a challenging but rewarding molecule to tame, given its sensitivity to moisture and certain transition metals. Verification methods, from GC-MS to NMR, form the backbone of our assurance strategy.

    Model and Specifications Built from the Ground Up

    Years ago, we recognized that off-the-shelf standards couldn't keep up with the rising standards of pharmaceutical and fine chemical sectors. Instead of generalizing, we honed practices for targeted purification. Material produced in our reactors regularly exceeds purity requirements—meeting or exceeding 98% assay as tested by both our own protocol and independent labs. Our process minimizes side products, especially any that can interfere with the next steps in a customer's synthetic pathway.

    We go beyond minimum compliance for heavy metal content, water, and residual solvents. For example, the limit of water by Karl Fischer titration is kept below 0.3%, a threshold based on what end-users report as critical for downstream chemistry. It's common for contract partners to submit their own microanalysis audits; being open to third-party scrutiny keeps our own teams motivated and focused on measurable outcomes.

    Practical Usage: Experience Brings Precision

    End users, whether academic or industrial, draw value from N-Methylhomoveratrylamine due to its role as a methylated amine building block with the electron-rich veratryl motif. We’ve witnessed increased demand from labs working on alkaloid synthesis, where this molecule provides a reliable handle for C-N bond construction. Some groups focus on central nervous system drug candidates, exploring the 3,4-dimethoxybenzyl pattern as part of their structure-activity studies.

    Teams that adopt this molecule in custom synthesis or scale-up programs notice both its atom efficiency and responsiveness to reductive amination protocols. If the target compound involves a dimethoxybenzyl unit, choosing the N-methyl derivative often trims down the protection-deprotection steps required elsewhere. These are lessons learned through joint projects with customers: we’ve sat in meetings listening to process chemists air frustrations about hard-to-handle intermediates and shared in the relief when a well-made batch proves dependable.

    Unlike general alkylamines or benzylamines, N-Methylhomoveratrylamine’s electron-donating aromatic system boosts nucleophilic strength at nitrogen, which affects not just yield, but also selectivity in cyclization and functionalization reactions. Our on-site production team reviews each customer’s use case to refine packaging protocols, ensuring inert atmosphere fill and HDPE containers maintain product stability. We have come across scenarios where even a few hours in the wrong container led to product degradation—a costly lesson that fuels our diligence.

    Insights into Real-World Differences Compared to Other Amines

    On paper, the difference between N-Methylhomoveratrylamine and the broader category of homologous amines might seem subtle; in reality, it’s significant. Even a few extra methyl groups or methoxy substitutions shift the electronic environment around the amine group. This adjustment translates into sharper reactivity profiles and alternate selectivity in standard coupling reactions. In our hands, substituting a regular benzylamine for N-Methylhomoveratrylamine never gives identical conversion or ease of purification, particularly when working with sensitive aromatic halides.

    Industry trends show a marked shift away from plain benzylamines in medicinal chemistry due to metabolic lability. The veratryl frame found in this compound resists enzymatic modification, which appeals to groups tuning their molecules for improved pharmacokinetics. We watch for these signals—not just in published literature but in real-time requests and purchasing spikes. When our production planners see upticks, they alert R&D to double-check related synthetic steps for any needed upgrades.

    Unlike tertiary amines or fully protected variants, the secondary nature and methyl group on N-Methylhomoveratrylamine strike a balance between reactivity and stability. Shelf life consistently surpasses 18 months under proper storage, based on long-term lot testing in our environmental stability chambers. We avoid adding unnecessary stabilizers or diluents. Nearly all feedback confirms that users see no residue after evaporation—a crucial requirement in pharmaceutical research.

    Meeting Evolving Industry Demands with Knowledge and Integrity

    Our factory doesn't run on assumptions. We invite chemists to tour, audit our lines, and look over our production logs. Trust comes from transparency, and chemical manufacturing today faces rising scrutiny, both from regulatory bodies and clients. E-E-A-T principles—especially the "Experience" part—play out at ground level, where batch consistency means more than just a checkmark on a specification sheet. It means chemistry teams can commit to long-term projects confidently, knowing their inputs won’t change unexpectedly.

    Traceability down to the raw material lot forms the backbone of our in-house quality systems. Each drum carries a unique identifier, linking it to spectroscopic and chromatographic records. This hands-on attention answers a common request from customers: certainty that what arrives next month will match what proved successful in this quarter’s pilot run.

    A recent partnership illustrated this approach. A drug development company came to us struggling with reproducibility during late-stage amination. After running diagnostics together, we traced the issue to a non-homogenous supply from a third-party blender. Once we shipped our certified batch, the reported conversion improved by more than 10%, and unwanted byproducts dropped sharply. Stories like this reinforce our belief that high standards on the manufacturing floor ripple through to innovation at the end user.

    Safety, Responsibility, and Environmental Impact

    Manufacturing N-Methylhomoveratrylamine safely demands respect for both human and environmental health. Internal guidelines extend far beyond basic compliance, including extensive air scrubbing, solvent recovery, and procedures that reduce the risk of exposure during handling. Workers receive ongoing education about personal protection and waste segregation, and we conduct routine drills on containment in case of a spill or system malfunction.

    We have learned—sometimes the hard way—that minor lapses during scale-up can have outsized consequences. Early pilot batches highlighted this molecule’s exothermic response in certain oxidation steps, prompting redesigns of venting and cooling setups. Our engineers have since implemented in-line monitoring for both pressure and temperature, lessening the likelihood of thermal runaway or vent releases. These measures reflect advice from both international safety bodies and sharp-eyed process safety engineers on our team.

    Once the manufacturing stream ends, responsibility shifts to safe shipping and customer education on best handling practices. Our technical support answers questions about storage, shelf life, and suitable diluents, discussing the tradeoffs between cost and safety measures based on project size and urgency. Throughout, we publish environmental impact data for each production run—covering solvent recycling rates, energy consumption, and waste dilution outcomes. Customers share this interest, using supplier data to bolster their own sustainability reports.

    Addressing Common Challenges with Real Solutions

    We have seen firsthand where problems arise with N-Methylhomoveratrylamine. Moisture contamination crops up most frequently, especially over long-distance shipments or in humid environments. Our team tested a range of desiccants in transit, finally settling on a system that keeps weight and cost low without sacrificing absorption. Batch data now shows less than 0.1% water uptake over 90 days under worst-case logistics conditions.

    Other pain points often turn up in downstream use—such as catalytic hydrogenations that falter due to trace oxidants or residual metal ions. We redesigned purification to target these, resulting in amines with heavy metal contents well below accepted industry maxima. Open feedback channels help here: instead of dismissing reported incidents, we encourage users to send back samples for joint investigation. This direct feedback loop drives steady improvement, benefitting both research and large-scale manufacturing partners.

    Discussions with research groups and commercial processors reveal another priority—the need for accessible technical documentation. We respond with in-depth COAs, but also field technical calls to walk through analytical signals, optimal reaction conditions, and troubleshooting tips for different scales. Our technical team draws from both the literature and our manufacturing history, so users gain insights grounded in both theory and repeated hands-on trials.

    Looking Ahead: Continuous Improvement through Collaboration

    N-Methylhomoveratrylamine's story does not stop at production. It continues in the benches and pilot plants of those who adopt it into their developmental pathways. We encourage open communication; when customers propose new uses or present challenges—unusual impurities, unexpected reactivity, scaling issues—our process scientists engage directly. Sometimes this leads to small tweaks: adjusting a crystallization solvent, swapping container linings, revisiting trace impurity thresholds; always seeking longer shelf life, safer handling, or even a more concentrated form.

    Manufacturing doesn’t flourish in a vacuum. We regularly update methodologies, not only to satisfy revised regulatory checklists but because the needs of customers shift as science and technology move forward. N-Methylhomoveratrylamine’s market keeps growing as new applications emerge—each with fresh challenges, whether in drug synthesis, agrochemical development, or advanced materials. Our teams track these, investing in pilot lots and feasibility studies before moving to full production, so that no new application catches us unprepared.

    Our company’s role as manufacturer places us at the coalface of both supply and technical advancement. While third-party traders might view this product as just another line item, those who spend day after day refining the chemistry grasp that end-use requirements dictate how each batch is made, authenticated, and delivered.

    Commitment Rooted in Experience, Delivering Results

    Supplying N-Methylhomoveratrylamine remains an ongoing education in what chemists want and why smart sourcing pays off. Our approach leans on honesty about capabilities, direct acknowledgment of challenges, and a track record of finding solutions rather than making promises that can’t be substantiated. Each improvement in our process reflects a story: an engineer studying a distillation curve, a quality officer catching a subtle chromatogram shift, a customer’s analytical chemist reporting a trace impurity that could have gone unnoticed.

    We draw confidence from this shared pool of effort and discovery, always recognizing that product integrity and technical support matter. In an industry where small differences in quality and responsiveness influence both scientific outcomes and commercial success, we hold ourselves to the standards shaped by both our experience and the evolving landscape of end use.

    With N-Methylhomoveratrylamine, the path between raw material and final application is paved by teamwork—our hands-on understanding of both molecule and market dovetailing with the expertise and ambitions of the chemists we serve.